Trademark Attorney / Law Firm
EDMUND R. PAPAZIAN – Trademark Portfolio
EDMUND R. PAPAZIAN specializes in Class 5 (Pharmaceuticals) trademark filings before the United States Patent and Trademark Office (USPTO), with 3 of 6 total filings concentrated in this category. The practice also covers Class 37 (Building & Construction) along with 5 other Nice Classification classes. Filing activity spans from 1980 to 1987. Currently, 0 trademarks are registered.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
EDMUND R. PAPAZIAN's trademark practice covers 5 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademark applications has EDMUND R. PAPAZIAN filed?
EDMUND R. PAPAZIAN has filed 6 trademark applications with the United States Patent and Trademark Office (USPTO).
What trademark classes does EDMUND R. PAPAZIAN specialize in?
EDMUND R. PAPAZIAN has filed trademarks across 5 Nice Classification classes. The most common practice areas include Class 5 (Pharmaceuticals), Class 37 (Building & Construction), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 7 (Machinery). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
How long has EDMUND R. PAPAZIAN been filing trademarks?
EDMUND R. PAPAZIAN's trademark filing history with the USPTO spans from 1980 to 1987, covering 7 years of trademark practice. During this period, EDMUND R. PAPAZIAN has handled 6 trademark applications.
What is EDMUND R. PAPAZIAN's trademark registration success rate?
EDMUND R. PAPAZIAN has a 0% trademark registration rate, with 0 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.